000
| 02230cam 2200397zi 4500 |
---|
001 | 9.917447 |
---|
003 | CaOODSP |
---|
005 | 20240326093206 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 221117t20222022onc o f000 0 eng d |
---|
020 | |a9780660463018 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP2-4/2020E-1-PDF |
---|
245 | 00|aCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2020 : |bexecutive summary and key findings. |
---|
264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022. |
---|
264 | 4|c©2022 |
---|
300 | |a1 online resource (4 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aCover title. |
---|
500 | |a"Publication date: December 2022." |
---|
500 | |aIssued also in French under title: Programme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2020 : sommaire et faits saillants. |
---|
520 | |a"The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use (AMU) and antimicrobial resistance (AMR) in select foodborne bacterial species from people, animal, and food sources across Canada"--Page 1. |
---|
610 | 20|aCanadian Integrated Program for Antimicrobial Resistance Surveillance. |
---|
650 | 0|aDrug resistance in microorganisms|zCanada. |
---|
650 | 0|aAnti-infective agents|zCanada. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
775 | 08|tProgramme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2020 : |w(CaOODSP)9.917449 |
---|
794 | |tCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) : |b2022|w(CaOODSP)9.933607 |
---|
795 | |tCIPARS 2019 : |w(CaOODSP)9.905137 |
---|
856 | 40|qPDF|s542 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP2-4-2020-1-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/drugs-health-products/canadian-integrated-program-antimicrobial-resistance-surveillance-2020-executive-summary-key-findings.html |
---|